Therefore, insights into the multifaceted interactions between human complement proteins and pathogenic Candida species may allow us to develop promising approaches for therapeutic strategies targeting complement proteins involved in the pathogenesis of Candida infections. The gene discussed is VTN; the disease is candidiasis.